Skip to main content
SpringerLink
Log in

Metabolism of taxol by human and rat liver in vitro: A screen for drug interactions and interspecies differences

  • Original Article
  • Drug Metabolism, Species Differences, Drug Interactions
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Human liver slices, human liver microsomes, and rat liver microsomes were used to investigate the metabolism of3H-taxol. The effects of drugs frequently coadministered with taxol and the effects of several cytochrome P450 system probes were studied. In all, 16 compounds were screened. After incubation with liver slices or with microsomal protein,3H-taxol was converted into several radioactive species resolved by HPLC. There were qualitative and quantitative species differences in the metabolism of taxol. The pattern of metabolism was similar for both human-derived preparations, with 6α-hydroxytaxol being the major metabolite peak. In drug interaction studies performed with human liver microsomes, cimetidine 80 μM, and diphenhydramine 200 μM, had little or no effect on 6α-hydroxytaxol formation. Quinidine, ketoconazole, dexamethasone and Cremophor EL inhibited 6α-hydroxytaxol formation with IC50 values of 36 μM, 37 μM, 16 μM and 1 μl/ml, respectively, but these concentrations exceed the usual clinical range. Cremophor EL also inhibited microsomal metabolism of taxol, but at 2 μl/ml it had little or no effect on 6α-hydroxytaxol production by human liver slices. These results suggest that: (1) taxol is metabolized by the cytochrome P450 system; (2) taxol metabolism is different in humans than in rats; (3) taxol metabolism in humans is unlikely to be altered by cimetidine, dexamethasone, or diphenhydramine, drugs regularly coadministered with taxol; (4) taxol metabolism can be indirectly affected by Cremophor EL, the formulation vehicle; (5) taxol metabolism may be altered by concentrations of ketoconazole achievable in humans only at very high doses; and (6) taxol metabolism and drug interaction studies of clinical relevance can be performed in vitro with human liver microsomes and human liver slices, but not with rat liver preparations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248

    Google Scholar 

  2. Brown T, Havlin K, Weiss G, Cagnola J, Koeller J, Kuhn J, Rizzo J, Craig J, Phillips J, Von Hoff D (1991) A phase I trial of taxol given by a 6-hour intravenous infusion. J Clin Oncol 9: 1261

    Google Scholar 

  3. Carruthers SG, Shoeman DW, Hignite CE, Azarnoff DL (1978) Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther 23:375

    Google Scholar 

  4. Cragg GM, Snader KM (1991) Taxol: the supply issue. Cancer Cells 3:233

    Google Scholar 

  5. Cresteil T, Monsarrat B, Alvinerie P, Tréluyer JM, Vieira I, Wright M (1994) Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation. Cancer Res 54:386

    Google Scholar 

  6. Daneshmend TK, Warnock DW (1988) Clinical pharmacokinetics of ketoconazole. Clin Pharmacokinet 14:13

    Google Scholar 

  7. Douglas WW (1985) Histamine and 5-hydroxytryptamine (serotonin) and their antagonists. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) The Pharmacological basis of therapeutics, 7th edn, Macmillan, New York, p 605

    Google Scholar 

  8. Einzig AI, Hochster H, Wiernik PH, Trump DL, Dutcher JP, Garowski E, Sasloff J, Smith TJ (1991) A phase II study of taxol in patients with malignant melanoma. Invest New Drugs 9:59

    Google Scholar 

  9. First MR, Schroeder TJ, Weiskittel P, Myre SA, Alexander JW, Pesce AJ (1989) Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients. Lancet 2:1198

    Google Scholar 

  10. Follath F, Ganzinger U, Schuetz E (1983) Reliability of antiarrhythmic drug plasma concentration monitoring. Clin Pharmacokinet 8:63

    Google Scholar 

  11. Guengerich FP, Muller-Enoch D, Blair IA (1986) Oxidation of quinidine by human liver cytochrome P-450. Mol Pharmacol 30:287

    Google Scholar 

  12. Harris JW, Katki A, Anderson LW, Chmurny GN, Paukstelis JV, Collins JM (1994) Isolation, structural determination, and biological activity of 6α-hydroxytaxol, the principal human metabolite of taxol. J Med Chem 37:706

    Google Scholar 

  13. Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN (1991) Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83:1797

    Google Scholar 

  14. Holton RA, Somoza C, Kim HB, Liang F, Biediger RJ, Boatman PD, Shindo M, Smith CC, Kim SC, Nadizadeh H, Suzuki Y, Tao CL, Vu P, Tang SH, Zhang PS, Murthi KK, Gentile LN, Liu JH (1994) First total synthesis of taxol. 1. Functionalization of the B ring. J Am Chem Soc 116:1597

    Google Scholar 

  15. Holton RA, Kim HB, Somoza C, Liang F, Biediger RJ, Boatman PD, Shindo M, Smith CC, Kim SC, Nadizadeh H, Suzuki Y, Tao CL, Vu P, Tang SH, Zhang PS, Murthi KK, Gentile LN, Liu JH (1994) First total synthesis of taxol. 2. Completion of the C and D rings. J Am Chem Soc 116:1599

    Google Scholar 

  16. Klecker RW, Jamis-Dow CA, Egorin MJ, Erkmen K, Parker RJ, Stevens R, Collins JM (1994) Effect of cimetidine, probenecid and ketoconazole on the distribution, biliary secretion and metabolism of3H-taxol in the sprague-dawley rat. Drug Metab Dispos 22:254

    Google Scholar 

  17. Knodell RG, Browne DG, Gwozdz GP, Brian WR, Guengerich FP (1991) Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology 101:1680

    Google Scholar 

  18. Kumar GN, Oatis JEJ, Thornburg KR, Heldich FJ, Hazard ESI, Walle T (1994) 6α-Hydroxytaxol: isolation and identification of the major metabolite of taxol in human liver microsomes. Drug Metab Dispos 22:177

    Google Scholar 

  19. Maurice M, Pichard L, Daujat M, Fabre I, Joyeux H, Domergue J, Maurel P (1992) Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J 6:752

    Google Scholar 

  20. McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK, Donehower RC (1989) Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 111:273

    Google Scholar 

  21. Monsarrat B, Mariel E, Cros S, Garès M, Guénard D, Guéritte-Voegelein F, Wright M (1990) Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile. Drug Metab Dispos 18:895

    Google Scholar 

  22. Monsarrat B, Alvinerie P, Wright M, Dubois J, Guéritte-Voegelein F, Guénard D, Donehower RC, Rowinsky EK (1993) Hepatic metabolism and biliary excretion of taxol in rats and humans. J Natl Cancer Inst Monogr 15:39

    Google Scholar 

  23. Nicolaou KC, Yang Z, Liu JJ, Ueno H, Nantermet PG, Guy RK, Claiborne CF, Renaud J, Couladouros EA, Paulvannan K, Sorensen EJ (1994) Total synthesis of taxol. Nature 367:630

    Google Scholar 

  24. Peereboom DM, Donehower RC, Eisenhauer EA, McGuire WP, Onetto N, Hubbard JL, Piccart M, Gianni L, Rowinsky EK (1993) Successful re-treatment with taxol after major hypersensitivity reactions. J Clin Oncol 11:885

    Google Scholar 

  25. Pichard L, Fabre I, Daujat M, Domergue J, Joyeux H, Maurel P (1992) Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes. Mol Pharmacol 41:1047

    Google Scholar 

  26. Reed E, Sarosy G, Jamis-Dow CA, Klecker R, Kohn E, Link C, Christian M, Davis P, Collins J (1993) Cimetidine does not influence taxol steady-state plasma levels. Proc Am Assoc Cancer Res 34:395

    Google Scholar 

  27. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT (1971) Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93:2325

    Google Scholar 

  28. Webster L, Linsenmeyer M, Millward M, Morton C, Bishop J, Woodcock D (1993) Measurement of Cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype. J Natl Cancer Inst 85: 1685

    Google Scholar 

  29. Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, Baker J Jr, Van Echo DA, Von Hoff DD, Leyland-Jones B (1990) Hypersensitivity reactions from taxol. J Clin Oncol 8:1263

    Google Scholar 

  30. Wilson WH, Berg SL, Bryant G, Wittes RE, Bates S, Fojo A, Steinberg SM, Goldspiel BR, Herdt J, O'Shavghnessy J, Balis FM, Chabner BA (1994) Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion. J Clin Oncol 12:1621

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pharmacology, Office of Research Resources, Center for Drug Evaluation and Research, Food and Drug Administration, 4 Research Court, Room 314, 20850, Rockville, MD, USA

    Carlos A. Jamis-Dow, Raymond W. Klecker, Aspandiar G. Katki & Jerry M. Collins

  2. Medicine Branch, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, 20892, Bethesda, MD, USA

    Carlos A. Jamis-Dow

Authors
  1. Carlos A. Jamis-Dow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raymond W. Klecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aspandiar G. Katki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jerry M. Collins
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jamis-Dow, C.A., Klecker, R.W., Katki, A.G. et al. Metabolism of taxol by human and rat liver in vitro: A screen for drug interactions and interspecies differences. Cancer Chemother. Pharmacol. 36, 107–114 (1995). https://doi.org/10.1007/BF00689193

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00689193

Key words

Search

Navigation